Parker Institute For Cancer Immunotherapy


Date of Award

11.21.2017

Program

Type 1 Diabetes, Prevent & Delay

Amount

$440,000

Term of Grant

30 months

Project Title

Identification of antigen-specific responses in patients with autoimmune endocrinopathies following checkpoint inhibition in cancer immunotherapy

Project Description

Funds to support studies to understand the pathogenesis of autoimmunity associated with cancer immunotherapy which may (1) help prevent and manage it, and (2) begin revealing the relationship between a new form of autoimmune diabetes and common forms of T1D.